Owl Creek Asset Management’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Owl Creek Asset Management’s Portfolio VHAQ Stock Details VHAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-61,680	Closed	-$679K	–	134
2023 Q2	$679K	Hold	61,680	–	–	0.03%	81
2023 Q1	$675K	Buy	+61,680	New	+$659K	0.03%	105

Other funds holding VHAQ

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

BCK Capital Management Stamford, Connecticut $23M AUM 32.69% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Owl Creek Asset Management's VHAQ Position: Q3 2023 in Review

Owl Creek Asset Management sold out of Viveon Health Acquisition Corp. (VHAQ) in Q3 2023, closing a stake of 61,680 shares — an estimated $679K sold.

Owl Creek Asset Management first reported a position in VHAQ in Q1 2023 and held it in 2 quarters. The position peaked at $679K in Q2 2023. 8 funds tracked by Wall St. Rank hold VHAQ as of Q3 2023.

Owl Creek Asset Management reported no remaining Viveon Health Acquisition Corp. position as of Q3 2023 after selling out during the quarter.
Owl Creek Asset Management sold 61,680 Viveon Health Acquisition Corp. shares in Q3 2023, an estimated $679K.
Owl Creek Asset Management first reported a position in Viveon Health Acquisition Corp. in Q1 2023 and held it in 2 quarters.
Owl Creek Asset Management's Viveon Health Acquisition Corp. position peaked at $679K in Q2 2023.
8 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q3 2023.

Based on Owl Creek Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.